How will a Labour government support the UK clinical trials industry?
The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?
05 July 2024
05 July 2024
The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?
Advances in automation in T-cell production are beginning to help make life-changing therapies more accessible to a growing number of patients in oncology and beyond.
As Finland administers the world’s first avian influenza vaccine for humans, the WHO says H5N1 has “pandemic potential”.
Viatris signed a deal with Cooper Consumer Health, divesting its OTC pipeline and two European manufacturing facilities.
SL-APO is marketed by Bial in France, Germany, Spain and the UK for the on-demand treatment of leveodopa wear-off.
Exploratory analysis of Lymphoseek failed to predict which rheumatoid arthritis patients would respond to treatment with anti-TNFα therapy.
The application, submitted on 4 June 2024, is based on data from the Phase III PIVOTAL study and a Phase II trial.
Offering the same medication as existing Vabysmo vials, the PFS provides an alternative, ready-to-use option.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.